MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
64 hedge funds and large institutions have $84M invested in Mirati Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+2
Holders Change %
+3.23%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
26
Reduced
14
Closed
7
Calls
$48K
Puts
$116K
Net Calls
-$68K
Net Calls Change
+$15K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$6.58M |
| 2 |
AH
Aviva Holdings
New Providence,
Bahamas
|
+$4.63M |
| 3 |
BlackRock
New York
|
+$4.59M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$4.55M |
| 5 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$3.77M |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.13M |
| 2 |
RI
RTW Investments
New York
|
-$616K |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$383K |
| 4 |
Millennium Management
New York
|
-$227K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$161K |
